Ablytx
Ablytx is a biotech company in San Diego, United States, founded in 2026.
Precision Proteolysis at the Cell Surface
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2026
- Business Model
- B2B
- Website
- ablytx.com
About
Ablytx develops Sheddase-Targeting Chimeras, or SHEDTACs, using bispecific antibodies to recruit membrane proteases that cut disease-driving proteins off the cell surface. Their binding arms determine which protein is shed while leaving adjacent off-target receptors unaffected. The approach removes targets at the cell surface without requiring trafficking, and the SHEDTACs remain preclinical.
Summary
It lists 11–50 employees.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ablytx"><img src="https://indexed.vc/api/badge/company/ablytx" alt="Ablytx on Indexed.vc" width="260" height="76" /></a>